Stroke Recurrence clinical trials

Explore recruiting stroke recurrence clinical trials.

Recruiting stroke recurrence studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stroke Recurrence trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of Tocilizumab in association to steroids in giant cell arteritis with cerebro-vascular involvement patients (ToGiAS). A french prospective multicentre randomized versus placebo phase III trial (TOGIAC)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study. An international, multicentre, randomised-controlled, two-arm, assessor-blinded trial.

Greece, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

High Dose Steroids in Children with Stroke and Unilateral Focal Arteriopathy: A Multicentre Randomized Controlled Trial

France, Austria, Germany, Denmark, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

The safety and efficacy of acute subcutaneous administration of semaglutide in non-diabetic patients with acute ischemic stroke: a multicentre, phase 2, prospective, randomized, open-label, blinded endpoint trial (ASSET)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Stroke Recurrence trials by city

Stroke Recurrence in Toronto Stroke Recurrence in Vancouver Stroke Recurrence in Montreal Stroke Recurrence in Calgary Stroke Recurrence in Edmonton Stroke Recurrence in Ottawa Stroke Recurrence in Winnipeg Stroke Recurrence in Quebec City Stroke Recurrence in Hamilton Stroke Recurrence in Kitchener Stroke Recurrence in London Stroke Recurrence in Halifax Stroke Recurrence in New York Stroke Recurrence in Los Angeles Stroke Recurrence in Chicago Stroke Recurrence in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease